KURA - Kura Oncology GAAP EPS of -$0.52 in-line August, 03 2022 04:34 PM Kura Oncology Inc. Kura Oncology press release ( NASDAQ: KURA ): Q2 GAAP EPS of -$0.52 in-line. $450 million in cash, cash equivalents and investments provide runway through 2024 For further details see: Kura Oncology GAAP EPS of -$0.52 in-line